US Patent Office Signals Patent for IRLAB Therapeutics’ IRL1117 Candidate
The US Patent Office has indicated that a patent for IRLAB Therapeutics’ drug candidate IRL1117 is forthcoming.
The US Patent Office has indicated that a patent for IRLAB Therapeutics’ drug candidate IRL1117 is forthcoming.